State Street
PMVP icon

State Street’s PMV Pharmaceuticals PMVP Stock Holding History

State Street’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$227K Hold
183,178
– – ﹤0.01% 3854
2025
Q4 		$229K Buy
183,178
+25,600
+16% +$34.3K ﹤0.01% 3871
2025
Q3 		$221K Hold
157,578
– – ﹤0.01% 3885
2025
Q2 		$167K Hold
157,578
– – ﹤0.01% 3878
2025
Q1 		$172K Hold
157,578
– – ﹤0.01% 3862
2024
Q4 		$238K Buy
157,578
+12,500
+9% +$19.8K ﹤0.01% 3805
2024
Q3 		$216K Hold
145,078
– – ﹤0.01% 3810
2024
Q2 		$235K Sell
145,078
-640,912
-82% -$1.16M ﹤0.01% 3769
2024
Q1 		$1.34M Buy
785,990
+62,536
+9% +$117K ﹤0.01% 3398
2023
Q4 		$2.24M Buy
723,454
+46,829
+7% +$124K ﹤0.01% 3275
2023
Q3 		$4.15M Buy
676,625
+35,044
+5% +$241K ﹤0.01% 3013
2023
Q2 		$4.02M Sell
641,581
-133,419
-17% -$699K ﹤0.01% 3100
2023
Q1 		$3.7M Sell
775,000
-2,532,236
-77% -$17.8M ﹤0.01% 3107
2022
Q4 		$28.8M Sell
3,307,236
-589,814
-15% -$6.29M ﹤0.01% 1991
2022
Q3 		$46.4M Sell
3,897,050
-1,274,440
-25% -$18.4M ﹤0.01% 1634
2022
Q2 		$73.7M Buy
5,171,490
+2,605,945
+102% +$37.9M ﹤0.01% 1380
2022
Q1 		$53.4M Buy
2,565,545
+889,190
+53% +$15.7M ﹤0.01% 1717
2021
Q4 		$38.7M Sell
1,676,355
-141,987
-8% -$3.43M ﹤0.01% 1988
2021
Q3 		$54.2M Buy
1,818,342
+832,854
+85% +$26.6M ﹤0.01% 1752
2021
Q2 		$33.7M Buy
985,488
+375,368
+62% +$12.5M ﹤0.01% 2134
2021
Q1 		$20.1M Buy
610,120
+402,667
+194% +$15.9M ﹤0.01% 2365
2020
Q4 		$12.8M Buy
+207,453
New +$8.14M ﹤0.01% 2491

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street's PMVP Position: Q1 2026 in Review

State Street held its PMV Pharmaceuticals (PMVP) position steady in Q1 2026 at 183,178 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #3854.

State Street first reported a position in PMVP in Q4 2020 and has held it in 22 quarters since. The position peaked at $73.7M in Q2 2022. 69 funds tracked by Wall St. Rank hold PMVP as of Q1 2026.

  • State Street held 183,178 shares of PMV Pharmaceuticals worth $227K as of Q1 2026.
  • State Street left its PMV Pharmaceuticals share count unchanged in Q1 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3854 holding.
  • State Street first reported a position in PMV Pharmaceuticals in Q4 2020 and has held it in 22 quarters since.
  • State Street's PMV Pharmaceuticals position peaked at $73.7M in Q2 2022.
  • 69 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.